אפופרוסטנול טבע ® 0.5 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

EPOPROSTENOL AS SODIUM 0.5 MG

Disponível em:

SALOMON,LEVIN & ELSTEIN LTD

Código ATC:

B01AC09

Forma farmacêutica:

POWDER AND SOLVENT FOR SOLUTION FOR INFUSION

Via de administração:

I.V

Fabricado por:

TEVA PARENTERAL MEDICINES INC, USA

Grupo terapêutico:

EPOPROSTENOL

Indicações terapêuticas:

Epoprostenol Teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA class III and class IV patients who do not respond to conventional therapy.

Data de autorização:

2009-11-01